A detailed history of Bleakley Financial Group, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 32,034 shares of MRVI stock, worth $167,217. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,034
Previous 23,171 38.25%
Holding current value
$167,217
Previous $166 Million 60.46%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$6.84 - $9.73 $60,622 - $86,236
8,863 Added 38.25%
32,034 $266 Million
Q2 2024

Aug 12, 2024

SELL
$6.87 - $11.34 $44,256 - $73,052
-6,442 Reduced 21.75%
23,171 $166 Million
Q1 2024

May 08, 2024

BUY
$5.11 - $8.76 $29,908 - $51,272
5,853 Added 24.63%
29,613 $257 Million
Q4 2023

Jan 25, 2024

BUY
$4.7 - $9.87 $50,741 - $106,556
10,796 Added 83.28%
23,760 $156 Million
Q3 2023

Nov 14, 2023

BUY
$9.14 - $12.85 $118,490 - $166,587
12,964 New
12,964 $130 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $687M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.